The financials
Merit Medical Systems, Inc. by the numbers
Merit Medical Systems, Inc. (MMSI) reported revenue of $382M in Q1 2026 (quarter ended March 31, 2026), up 7.5% from the same quarter a year earlier. That came with a gross margin of 48% and net income of $41M (11% of revenue). For the full year FY2025, revenue was $1.52B (+12% year on year) and net income $128M. Its largest product in 2026-Q1 was Foundational at $255M, 67% of the disclosed total, just ahead of Therapeutic at 33%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $382M | $355M | +7.5% |
| Gross profit | $185M | $172M | +7.4% |
| Operating income | $44M | $41M | +7.6% |
| Net income | $41M | $30M | +36% |
| Diluted EPS | $0.68 | $0.49 | +39% |
| Product | Revenue | Share |
|---|---|---|
| Foundational | $255M | 67% |
| Therapeutic | $126M | 33% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $381.9M (+66%)
Therapeutic grew +9.9% year on yearFoundational +6.3% year on year
Segment Latestyear on year
- Foundational$255.5M$255.5Myear on year +6.3%+6.3%
- Therapeutic$126.4M$126.4Myear on year +9.9%+9.9%
- Cardiac Intervention--year on year --
- Custom Procedural Solutions--year on year --
- Endoscopy Devices--year on year --
- OEM--year on year --
- Peripheral Intervention--year on year --
Medical Instruments & Supplies
Ranks #14 of 27 by Smart Score